215 related articles for article (PubMed ID: 32503970)
21. Stroke-associated intergenic variants modulate a human FOXF2 transcriptional enhancer.
Ryu JR; Ahuja S; Arnold CR; Potts KG; Mishra A; Yang Q; Sargurupremraj M; Mahoney DJ; Seshadri S; Debette S; Childs SJ
Proc Natl Acad Sci U S A; 2022 Aug; 119(35):e2121333119. PubMed ID: 35994645
[TBL] [Abstract][Full Text] [Related]
22. MiR-200c inhibits metastasis of breast tumor via the downregulation of Foxf2.
Zhang T; Wan JG; Liu JB; Deng M
Genet Mol Res; 2017 Aug; 16(3):. PubMed ID: 28829888
[TBL] [Abstract][Full Text] [Related]
23. Forkhead box transcription factors in embryonic heart development and congenital heart disease.
Zhu H
Life Sci; 2016 Jan; 144():194-201. PubMed ID: 26656470
[TBL] [Abstract][Full Text] [Related]
24. Gastroparesis is associated with decreased FOXF1 and FOXF2 in humans, and loss of FOXF1 and FOXF2 results in gastroparesis in mice.
Herring BP; Hoggatt AM; Gupta A; Wo JM
Neurogastroenterol Motil; 2019 Mar; 31(3):e13528. PubMed ID: 30565344
[TBL] [Abstract][Full Text] [Related]
25. FOXF2 reprograms breast cancer cells into bone metastasis seeds.
Wang S; Li GX; Tan CC; He R; Kang LJ; Lu JT; Li XQ; Wang QS; Liu PF; Zhai QL; Feng YM
Nat Commun; 2019 Jun; 10(1):2707. PubMed ID: 31222004
[TBL] [Abstract][Full Text] [Related]
26. The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers.
Kundu ST; Byers LA; Peng DH; Roybal JD; Diao L; Wang J; Tong P; Creighton CJ; Gibbons DL
Oncogene; 2016 Jan; 35(2):173-86. PubMed ID: 25798833
[TBL] [Abstract][Full Text] [Related]
27. Decreased mRNA expression of transcription factor forkhead box F2 is an indicator of poor prognosis in patients with resected esophageal squamous cell carcinoma.
Zheng YZ; Wen J; Cao X; Yang H; Luo KJ; Liu QW; Huang QY; Chen JY; Fu JH
Mol Clin Oncol; 2015 May; 3(3):713-719. PubMed ID: 26137292
[TBL] [Abstract][Full Text] [Related]
28. FOXF2 promoter methylation is associated with prognosis in esophageal squamous cell carcinoma.
Chen X; Hu H; Liu J; Yang Y; Liu G; Ying X; Chen Y; Li B; Ye C; Wu D; Duan S
Tumour Biol; 2017 Feb; 39(2):1010428317692230. PubMed ID: 28222662
[TBL] [Abstract][Full Text] [Related]
29. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
[TBL] [Abstract][Full Text] [Related]
30. FOXF2 deficiency promotes hepatocellular carcinoma metastasis by inducing mesenchymal-epithelial transition.
Dou C; Jin X; Sun L; Zhang B; Han M; Li T
Cancer Biomark; 2017 Jul; 19(4):447-454. PubMed ID: 28582850
[TBL] [Abstract][Full Text] [Related]
31. Foxf2 and Smad6 co-regulation of collagen 5A2 transcription is involved in the pathogenesis of intrauterine adhesion.
Chen G; Liu L; Sun J; Zeng L; Cai H; He Y
J Cell Mol Med; 2020 Mar; 24(5):2802-2818. PubMed ID: 32022446
[TBL] [Abstract][Full Text] [Related]
32. FOXF2 aggravates the progression of non-small cell lung cancer through targeting lncRNA H19 to downregulate PTEN.
Xu JL; Hua T; Ding J; Fan Y; Liu ZJ; Lian JW
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10796-10802. PubMed ID: 31858547
[TBL] [Abstract][Full Text] [Related]
33. FOXF2 inhibits proliferation, migration, and invasion of Hela cells by regulating Wnt signaling pathway.
Zhang J; Zhang C; Sang L; Huang L; Du J; Zhao X
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30249755
[TBL] [Abstract][Full Text] [Related]
34. FOXF2 differentially regulates expression of metabolic genes in non-cancerous and cancerous breast epithelial cells.
Lo PK
Trends Diabetes Metab; 2018; 1(1):. PubMed ID: 30294731
[TBL] [Abstract][Full Text] [Related]
35. Decreased expression of FOXF2 as new predictor of poor prognosis in stage I non-small cell lung cancer.
Kong PZ; Li GM; Tian Y; Song B; Shi R
Oncotarget; 2016 Aug; 7(34):55601-55610. PubMed ID: 27487137
[TBL] [Abstract][Full Text] [Related]
36. miR-130b participates in wear particle-induced inflammation and osteolysis via FOXF2/NF-κB pathway.
Zheng DZ; Bu YM; Wang L
Immunopharmacol Immunotoxicol; 2018 Oct; 40(5):408-414. PubMed ID: 30488739
[TBL] [Abstract][Full Text] [Related]
37. Research progress on the regulation of tumor initiation and development by the forkhead box Q1 gene.
Tang H; Zhang J; Guo Q
J Cancer Res Ther; 2018 Jan; 14(1):6-11. PubMed ID: 29516951
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of Foxf2 in adipose tissue is associated with lower levels of IRS1 and decreased glucose uptake in vivo.
Westergren R; Nilsson D; Heglind M; Arani Z; Grände M; Cederberg A; Ahrén B; Enerbäck S
Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E548-54. PubMed ID: 20009030
[TBL] [Abstract][Full Text] [Related]
39. Genome-wide Identification of Foxf2 Target Genes in Palate Development.
Xu J; Liu H; Lan Y; Park JS; Jiang R
J Dent Res; 2020 Apr; 99(4):463-471. PubMed ID: 32040930
[TBL] [Abstract][Full Text] [Related]
40. Forkhead transcription factor Foxf2 (LUN)-deficient mice exhibit abnormal development of secondary palate.
Wang T; Tamakoshi T; Uezato T; Shu F; Kanzaki-Kato N; Fu Y; Koseki H; Yoshida N; Sugiyama T; Miura N
Dev Biol; 2003 Jul; 259(1):83-94. PubMed ID: 12812790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
